| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | SR02 | Genotype:PMM2-CDG | Treatment:5.5mM 12C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR06 | Genotype:PMM2-CDG | Treatment:5.5mM 12C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR04 | Genotype:PMM2-CDG | Treatment:5.5mM 12C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR08 | Genotype:PMM2-CDG | Treatment:5.5mM 12C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR01 | Genotype:PMM2-CDG | Treatment:5.5mM 13C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR05 | Genotype:PMM2-CDG | Treatment:5.5mM 13C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR03 | Genotype:PMM2-CDG | Treatment:5.5mM 13C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR07 | Genotype:PMM2-CDG | Treatment:5.5mM 13C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR10 | Genotype:WT | Treatment:5.5mM 12C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR14 | Genotype:WT | Treatment:5.5mM 12C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR12 | Genotype:WT | Treatment:5.5mM 12C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR16 | Genotype:WT | Treatment:5.5mM 12C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR09 | Genotype:WT | Treatment:5.5mM 13C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR13 | Genotype:WT | Treatment:5.5mM 13C GLU negative siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR11 | Genotype:WT | Treatment:5.5mM 13C GLU siRNA | AUC |
| Reversed phase NEGATIVE ION MODE | SR15 | Genotype:WT | Treatment:5.5mM 13C GLU siRNA | AUC |
Return to study ST002564 main page
Download data matrix(Metabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 and neuraminidase treatment Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|